North Dakota Cancer Coalition
Our strength is in partnership and collaboration with our Coalition members
The North Dakota Cancer Coalition is made up of partners from across the state who work together with the common goal of reducing the incidence and death of cancer among North Dakotans. North Dakota Cancer Coalition partners worked together to write North Dakota’s Cancer Control Plan.
Any organization or individual interested in working to reduce the incidence and death of cancer among North Dakotas may join the Coalition. As a North Dakota Cancer Coalition member, partners also have the option of receiving resources for their cancer prevention and control implementation efforts. Member dues are $50 per membership year beginning January 1, 2025.
Visit Our Sponsors
The appearance of hyperlinks does not constitute endorsement by the ND Cancer Coalition of this website, information, products or services contained therein.
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development and delivery of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast, lung and gastric cancer, tenosynovial giant cell tumor and iron deficiency anemia. Visit us at www.daiichisankyo.us.
Deciphera
Deciphera is a biopharmaceutical company focused on discovering and developing targeted therapies for patients with cancer, particularly those with difficult-to-treat tumors.
Women’s Way
Women’s Way is North Dakota’s Breast and Cervical Cancer Early Detection Program, providing eligible women with access to free or low‑cost breast and cervical cancer screenings, diagnostic services, and patient navigation to help overcome barriers to care. The program is administered by North Dakota Health and Human Services in partnership with local public health agencies statewide.
Syndax
Syndax is a clinical-stage biopharmaceutical company developing epigenetic therapies to treat cancer, focused on addressing areas of high unmet medical need.
Guardant Health
Guardant Health is a precision oncology company developing blood‑based and tissue genomic testing solutions to help detect cancer early, guide treatment decisions, and improve patient outcomes.
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook.
Tempus AI
AI-enabled precision medicine: Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.
Gilead Sciences
Gilead Sciences is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for serious diseases, including cancer, HIV, liver disease, and inflammation.
Pharmacosmos Therapeutics
Pharmacosmos Therapeutics specializes in iron deficiency therapies, developing treatments to improve outcomes for patients with chronic disease-related iron deficiency.
Bismarck Cancer Center
Bismarck Cancer Center provides comprehensive oncology care, offering advanced cancer treatment services close to home for patients in the region.
PharmaEssentia
PharmaEssentia is a biopharmaceutical company committed to advancing treatments for hematologic disorders and oncology through innovative biologic therapies.
GSK
GSK is a global biopharma company focused on vaccines, specialty medicines, and general medicines to prevent and treat disease and improve quality of life.